- Trials with a EudraCT protocol (51)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
51 result(s) found for: Alzheimer.
Displaying page 1 of 3.
EudraCT Number: 2014-001315-40 | Sponsor Protocol Number: RF-2010-2319722 | Start Date*: 2014-12-03 | |||||||||||
Sponsor Name:IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli | |||||||||||||
Full Title: Amyloid Imaging in the “Italian Network for autosomal dominant Alzheimer’s disease and frontotemporal lobar degeneration (ItalianDIAfN)” | |||||||||||||
Medical condition: Autosomal Dominant Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000798-26 | Sponsor Protocol Number: 20-AVP-786-306 | Start Date*: 2021-06-22 | |||||||||||||||||||||
Sponsor Name:Avanir Pharmaceuticals, Inc. | |||||||||||||||||||||||
Full Title: A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q... | |||||||||||||||||||||||
Medical condition: Agitation in patients with dementia of the Alzheimer’s type | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Ongoing) PT (Ongoing) PL (Ongoing) DK (Ongoing) BG (Ongoing) GR (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000799-39 | Sponsor Protocol Number: 20-AVP-786-307 | Start Date*: 2021-02-05 | |||||||||||||||||||||
Sponsor Name:Avanir Pharmaceuticals, Inc. | |||||||||||||||||||||||
Full Title: A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q... | |||||||||||||||||||||||
Medical condition: Agitation in patients with dementia of the Alzheimer’s type | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: HU (Ongoing) SK (Ongoing) NL (Ongoing) SI (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004368-22 | Sponsor Protocol Number: 221AD304 | Start Date*: 2020-08-26 | |||||||||||
Sponsor Name:Biogen Idec Research Limited | |||||||||||||
Full Title: Phase 3b Open-Label, Multicenter, Safety Study of BIIB037 (aducanumab) in Subjects With Alzheimer’s Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 an... | |||||||||||||
Medical condition: Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) DK (Ongoing) FI (Ongoing) AT (Ongoing) PL (Ongoing) PT (Ongoing) BE (Ongoing) GB (GB - no longer in EU/EEA) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004474-15 | Sponsor Protocol Number: PETFLUTEMETAMOL-FDG/BBRC2015 | Start Date*: 2016-03-14 | ||||||||||||||||
Sponsor Name:BarcelonaBeta Brain Research Center | ||||||||||||||||||
Full Title: Characterization of cerebral amyloid deposition with 18F-Flutemetamol PET and of glucose metabolism with 18F-FDG PET in individuals enrolled in the ALFA project | ||||||||||||||||||
Medical condition: Study to understand factors related with the preclinical stages of Alzheimer's Disease and investigate markers that predict its progression. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002783-88 | Sponsor Protocol Number: 331-201-00182 | Start Date*: 2018-12-27 | |||||||||||
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc. | |||||||||||||
Full Title: A 12-week, Multicenter, Active-treatment Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheim... | |||||||||||||
Medical condition: Agitation Associated With Dementia of the Alzheimer's Type | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Ongoing) ES (Ongoing) HU (Completed) SK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003362-17 | Sponsor Protocol Number: MPC-7869-05-009.02 | Start Date*: 2008-01-04 | |||||||||||
Sponsor Name:Myriad Pharmaceuticals, Inc | |||||||||||||
Full Title: Open Label Study of the Effect of Daily Treatment with MPC-7869 in Subjects with Dementia of the Alzheimer’s Type | |||||||||||||
Medical condition: Treatment of Alzheimer’s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) BE (Completed) DE (Prematurely Ended) NL (Ongoing) SE (Prematurely Ended) DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000077-25 | Sponsor Protocol Number: I5T-MC-AACI | Start Date*: 2020-07-13 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer’s Disease | |||||||||||||
Medical condition: Early Symptomatic Alzheimer’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004325-80 | Sponsor Protocol Number: ANAVEX2-73-AD-EP-004 | Start Date*: 2022-01-10 | |||||||||||
Sponsor Name:Anavex Germany GmbH | |||||||||||||
Full Title: Open Label Extension Study for Patients with Early Alzheimer’s Disease (AD) Enrolled in Study ANAVEX2-73-AD-004 | |||||||||||||
Medical condition: Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006490-24 | Sponsor Protocol Number: CL-758019 | Start Date*: 2007-04-19 | |||||||||||
Sponsor Name:Neurochem Inc | |||||||||||||
Full Title: An Open-Label Extension of the Phase III Study CL-758010 with Alzhemed™ in Patients with Alzheimer’s Disease. | |||||||||||||
Medical condition: Alzheimer's Disease (AD) is an irreversible, progressive neurodegenerative disorder, characterized by gradual cognitive decline, abnormal behaviour, and personality changes. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Ongoing) SE (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003302-27 | Sponsor Protocol Number: ANAVEX2-73-AD-004 | Start Date*: 2020-01-22 | |||||||||||
Sponsor Name:Anavex Germany GmbH | |||||||||||||
Full Title: A Phase 2b/3, Double-Blind, Randomised, Placebo-Controlled 48 week Safety and Efficacy trial of ANAVEX2-73 for the Treatment of Early Alzheimer’s Disease (AD). | |||||||||||||
Medical condition: Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) NL (Ongoing) DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002005-19 | Sponsor Protocol Number: TTP488-301 | Start Date*: 2016-08-19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:vTv THERAPEUTICS LLC | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, MULTI-CENTER REGISTRATION TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF TTP488 IN PATIENTS WITH MILD ALZHEIMER'S DISEASE RECEIVING ACETYLCHOLINESTERASE ... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: MILD ALZHEIMER'S DISEASE RECEIVING ACETYLCHOLINESTERASE INHIBITORS AND/OR MEMANTINE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) IE (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004739-58 | Sponsor Protocol Number: BAN2401-G000-301 | Start Date*: 2019-06-12 | ||||||||||||||||
Sponsor Name:Eisai Limited | ||||||||||||||||||
Full Title: A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer’s Disease | ||||||||||||||||||
Medical condition: Mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease dementia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Ongoing) ES (Ongoing) SE (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001755-41 | Sponsor Protocol Number: GV971-007 | Start Date*: 2021-02-10 | |||||||||||
Sponsor Name:Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | |||||||||||||
Full Title: A Phase 3, multi-center, randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the efficacy and safety of sodium oligomannate (GV-971) in treatment of mild to mode... | |||||||||||||
Medical condition: mild to moderate Alzheimer’s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) DE (Prematurely Ended) PL (Ongoing) NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003940-19 | Sponsor Protocol Number: 331-14-213 | Start Date*: 2018-08-06 | |||||||||||
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc. | |||||||||||||
Full Title: A Phase 3, 12-Week, Multicenter, Randomized, Double-blind, Placebo controlled, 2 Arm, Fixed-dose Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) in the Treatme... | |||||||||||||
Medical condition: Agitation Associated With Dementia of the Alzheimer’s Type | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) ES (Ongoing) HU (Completed) SK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003558-17 | Sponsor Protocol Number: TRx-237-039 | Start Date*: 2018-02-25 | |||||||||||
Sponsor Name:TauRx Therapeutics Ltd | |||||||||||||
Full Title: Randomized, Double-Blind, Placebo-Controlled, Three-Arm, 12-Month, Safety and Efficacy Study of Hydromethylthionine Mesylate (LMTM) Monotherapy in Subjects with Alzheimer's Disease Followed by a 12... | |||||||||||||
Medical condition: Alzheimer’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) PL (Ongoing) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021218-50 | Sponsor Protocol Number: AB09004 | Start Date*: 2011-05-25 | |||||||||||
Sponsor Name:AB Science | |||||||||||||
Full Title: A multicenter, double-blind, placebo-controlled, randomised, parallel-group phase 3 study to evaluate the safety and efficacy of masitinib in patients with mild to moderate Alzheimer’s disease | |||||||||||||
Medical condition: mild to moderate Alzheimer’s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prohibited by CA) ES (Completed) SK (Prohibited by CA) PL (Completed) GR (Completed) GB (GB - no longer in EU/EEA) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000307-17 | Sponsor Protocol Number: DIAN-TU-001 | Start Date*: 2014-01-08 |
Sponsor Name:Washington University in St. Louis | ||
Full Title: A Phase II/III randomized, double-blind, placebo-controlled, cognitive endpoint, multicenter study of potential disease modifying therapies in individuals at risk for and with dominantly inherited ... | ||
Medical condition: Dominantly Inherited Alzheimer Disease (DIAD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) IT (Ongoing) ES (Temporarily Halted) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000370-27 | Sponsor Protocol Number: COR388-010-UK | Start Date*: 2019-10-24 | |||||||||||
Sponsor Name:Cortexyme, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo Controlled Study of COR388 HCl in Subjects with Alzheimer’s Disease | |||||||||||||
Medical condition: Alzheimer’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) NL (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000860-10 | Sponsor Protocol Number: 10729 | Start Date*: 2006-06-30 |
Sponsor Name:H. Lundbeck A/S | ||
Full Title: An Open-Label Study Investigating the Specific Effects of Memantine in Institutionalised Patients with Alzheimer’s Disease | ||
Medical condition: Effects of memantine treatment in institutionalised patients with Alzheimer's Disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) BE (Completed) GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
